European Regulations

Indoxacarbo Extension as Biocide Type 18: What Changes for Manufacturers and Pest Control

E
Equipo Editorial CambiosLegales
Nov 20, 2026 6 min 10 views

Key data

RegulationCommission Implementing Decision (EU) 2026/2561, of 19 November 2026
Official referenceOJ:L_202602561
Publication20 November 2026
Entry into force19 November 2026
Legal basisRegulation (EU) No 528/2012 of the European Parliament and of the Council
Affected substanceIndoxacarb
Product typeType 18 — Insect control
Affected partiesManufacturers, distributors and professional users of biocides containing indoxacarb
CategoryEuropean Regulation
Year2026
Impact analysis reserved for subscribers
The detailed impact analysis of this regulation is available with the PRO and Business plans. Access the full content and receive personalized alerts.
From €9.99/month · Cancel anytime

If your company manufactures, distributes or professionally uses biocides containing indoxacarb for insect control, this decision affects you directly — and the news is positive: you can continue operating without interruption. The Implementing Decision (EU) 2026/2561, adopted on 19 November 2026 under the Regulation (EU) No 528/2012, delays the expiry date of indoxacarb approval for biocides of product type 18, ensuring market continuity while the renewal process is completed.

What does this regulation establish?

Indoxacarb is an active substance used in biocides classified as product type 18, a category that corresponds to the control of insects and other arthropods. Its approval at European level was subject to an expiry date, and the process of renewing that approval had not been completed before that deadline.

To prevent products containing indoxacarb from being placed in an illegal situation — which would have forced their withdrawal from the market and paralyzed the activity of manufacturers, distributors and pest control operators — the European Commission has adopted this Implementing Decision that delays the expiry date of the approval.

This measure is a common mechanism within the European biocide authorization system. When administrative renewal procedures extend beyond the original deadline, the Commission may temporarily extend the validity of the approval to preserve legal certainty in the sector.

ElementDetail
Active substanceIndoxacarb
Type of biocide productType 18 — Insect and arthropod control
Reason for extensionThe approval renewal process has not been completed before the original expiry date
Effect of the decisionDelay of the approval expiry date
Regulatory frameworkRegulation (EU) No 528/2012 on the marketing of biocides

Economic and operational impact

The economic impact of this decision is, in practical terms, neutral or positive for sector operators. The alternative to this extension would have been the expiry of the approval without renewal, which would have generated:

  • Obligation to withdraw from the market all biocide products containing indoxacarb as the active substance.
  • Paralysis of commercial activity for manufacturers and distributors of these products.
  • Interruption of service for companies and professionals in pest control that depend on these biocides.
  • Urgent need to reformulate products or seek alternative approved substances, with associated development and registration costs.

Thanks to the extension, none of these scenarios materialize. Products with indoxacarb type 18 maintain their legal status for marketing during the extended period, without operators having to incur additional immediate adaptation costs.

The only operational risk to monitor is tracking the renewal process: if renewal is ultimately not approved, or if it is approved with restrictive conditions, the sector will need to adapt at that time. Therefore, it is advisable to maintain active monitoring of the status of the renewal file with the European Chemicals Agency (ECHA).

Who does it affect?

  • Biocide manufacturers that formulate products with indoxacarb as the active substance for insect control (type 18).
  • Distributors and marketers of these products in the European market.
  • Pest control companies that professionally use biocides containing indoxacarb in their treatments.
  • Professional users of type 18 biocide products in sectors such as hospitality, food, logistics, facility management or agriculture.
  • Regulatory advisors and compliance officers in chemical and phytosanitary sector companies that manage the portfolio of approved active substances.

Practical example

A Spanish pest control company that provides services to restaurant chains regularly uses biocide products containing indoxacarb to treat cockroaches and other crawling insects (product type 18). Without this extension, from the original expiry date, those products would have lost their European authorization and the company would not have been able to continue applying them legally.

Thanks to Implementing Decision (EU) 2026/2561, the company can continue using those products without modifying its work protocols, without reformulating the biocides and without seeking emergency alternatives. Its activity is legally supported throughout the extension period, while the European Commission completes the process of renewing indoxacarb approval.

Do you need to track this and other regulations?

Check the full details on CambiosLegales

What should companies do now?

  1. Verify that affected products are correctly identified in your portfolio: check which biocides in your catalog contain indoxacarb as the active substance and are classified as product type 18.
  2. Communicate legal continuity to your commercial and operational teams: sales, purchasing and operations managers should know that these products remain legal and marketable during the extended period.
  3. Monitor the renewal process with the ECHA: the extension is temporary. Follow the status of the indoxacarb renewal file to anticipate possible changes in approval conditions or potential non-renewal.
  4. Review the national authorizations of your products: European approval of the active substance is the first level, but biocide products also require national authorization. Verify that the authorizations of your specific products are current and aligned with the European extension.
  5. Prepare a contingency plan: although the extension guarantees short-term continuity, it is prudent to identify alternative approved active substances for type 18, in case the renewal process concludes with restrictions or denial.

Frequently asked questions

What is biocide product type 18 and what products does it include?

Product type 18, according to Regulation (EU) No 528/2012, corresponds to biocides intended for the control of insects and other arthropods. It includes products used professionally to eliminate or control cockroaches, ants, flies, mosquitoes and other insects in domestic, industrial, hospitality and agricultural environments. Indoxacarb is one of the approved active substances for this product type.

Can I continue selling and using products containing indoxacarb after this decision?

Yes. Implementing Decision (EU) 2026/2561, in force since 19 November 2026, delays the expiry date of indoxacarb approval for type 18 biocides. This means that products containing this active substance maintain their legal status for marketing and use during the extended period, without requiring any additional action by manufacturers, distributors or professional users.

Why has indoxacarb approval been extended rather than directly renewed?

Because the approval renewal process has not been completed before the original expiry date. Within the European biocide authorization system (EU Regulation 528/2012), when administrative renewal procedures extend beyond the planned deadline, the Commission may temporarily extend the validity of the approval to avoid a regulatory gap. It is a common technical measure that ensures legal certainty in the sector while the evaluation is completed.

When does the extension end and what will happen next?

Implementing Decision (EU) 2026/2561 does not specify a specific end date for the extension in the available data: the extension is linked to the completion of the indoxacarb approval renewal process. Once the European Commission completes that evaluation, it will publish a new decision establishing the definitive approval conditions (or, where applicable, non-renewal). It is recommended to follow the status of the file through the ECHA.

Does this extension affect national authorizations of biocide products containing indoxacarb?

The extension of European approval of the active substance indoxacarb is the first regulatory level. However, specific biocide products also require national authorization in each Member State. Companies must verify that the national authorizations of their specific products are current and consistent with the European extension, as both levels must be aligned for marketing to be legal.

Official source

Consult full regulation at official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602561



Share:
E
Equipo Editorial CambiosLegales

El equipo editorial de CambiosLegales analiza diariamente los cambios normativos que afectan a empresas y autónomos en España, ofreciendo análisis pro...

Comments

No comments yet. Be the first to comment!

Leave a comment
Activate alerts

Almost there